|
1 Indications And Usage Fluvoxamine Maleate Extended-Release Capsules Are Selective Serotonin Reuptake Inhibitor (Ssri) Indicated For The Treatment Of Obsessive Compulsive Disorder (Ocd) ( 1 ). Efficacy Was Demonstrated In: One 12-Week Study With Fluvoxamine Maleate Extended-Release Capsules In Adults ( 14.1 ) . Two 10-Week Studies With Immediate-Release (Ir) Fluvoxamine Tablets In Adults And One 10-Week Study With Ir Fluvoxamine Tablets In Children And Adolescents ( 14.1 , 14.3 ) . One Maintenance Study With Ir Fluvoxamine Tablets ( 14.2 ) . 1.1 Obsessive Compulsive Disorder Fluvoxamine Maleate Extended-Release Capsules Are Indicated For The Treatment Of Obsessive Compulsive Disorder (Ocd), As Defined In The Dsm-Iv. Obsessive Compulsive Disorder Is Characterized By Recurrent And Persistent Ideas, Thoughts, Impulses, Or Images (Obsessions) That Are Ego-Dystonic And/or Repetitive, Purposeful, And Intentional Behaviors (Compulsions) That Are Recognized By The Person As Excessive Or Unreasonable. The Obsessions Or Compulsions Cause Marked Distress, Are Time-Consuming, Or Significantly Interfere With Social Or Occupational Functioning. The Efficacy Of Fluvoxamine Maleate Extended-Release Capsules Was Demonstrated In One 12-Week Trial In Adults With Fluvoxamine Maleate Extended-Release Capsules As Well As In Two 10-Week Trials In Adults And In One 10-Week Trial In Children And Adolescents (Ages 8 To 17 Years) With Immediate-Release Fluvoxamine Tablets In Outpatients With The Diagnosis Of Ocd As Defined In Dsm-Iv Or Dsm-Iii-R (See Clinical Studies [14.1 , 14.3] ). The Efficacy Of Fluvoxamine For Long-Term Use Was Established In One Maintenance Study In Adults With Immediate-Release Fluvoxamine Tablets (See Clinical Studies [14. 2 ] ). The Health Care Provider Who Elects To Prescribe Fluvoxamine Maleate Extended-Release Capsules For Extended Periods Should Periodically Re-Evaluate The Long-Term Usefulness Of The Drug For The Individual Patient (See Dosage And Administration [2.4] ).
|